1.50Open1.50Pre Close0 Volume257 Open Interest35.00Strike Price0.00Turnover854.49%IV253.34%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.3195Delta0.0298Gamma6.89Leverage Ratio-0.3201Theta0.0003Rho2.20Eff Leverage0.0050Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet